Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

BOCA RATON, Fla., Oct. 11, 2017Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radio Therapy (SRT), today announced that management will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 12:00 p.m. Eastern time. The conference will be held at the Wyndham Grand Hotel in Jupiter, Florida on October 18-19, 2017.

Sensus Healthcare logo. (PRNewsFoto/Sensus Healthcare)

The presentation will be webcast live and available for replay in the Investor Relations section of the Company’s website at www.sensushealthcare.com.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit www.sensushealthcare.com.

Contact:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
[email protected]

View original content with multimedia:https://www.prnewswire.com/news-releases/sensus-healthcare-to-present-at-dawson-james-securities-3rd-annual-small-cap-growth-conference-300534573.html

SOURCE Sensus Healthcare

Share this article

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

98.7%+
Non Reoccurrence Rate

No anesthesia, cutting, bleeding, stitching or pain

No downtime or lifestyle restrictions

Super cosmesis, no unsightly scarring

No need for post-treatment reconstructive surgeries

Patient Inquiry

Patient Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE

Physician Inquiry

Physician Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE

General Inquiry

General Inquiry

Discover how Sensus Healthcare and the SRT-100TM are removing the physical and emotional pain often associated with skin cancer treatment.
LEARN MORE